<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Partial excess of chromosome 1 (q25-q32) was noted in malignant cells from <z:hpo ids='HP_0000001'>all</z:hpo> of 10 patients who had disorders such as non-African Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, adult T-cell <z:hpo ids='HP_0001909'>leukemia</z:hpo>, <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo>, malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> or <z:hpo ids='HP_0011010'>chronic</z:hpo> myelocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> in <z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">blast crisis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The break points on chromosome 1 were at centromere, q12, q21, q23, q25 and q32 </plain></SENT>
<SENT sid="2" pm="."><plain>Variations in the specific region of the long arm of chromosome 1, q25-q32, were thought to be important in the evolution of malignant cell proliferation </plain></SENT>
</text></document>